Global MarketsIMPORTANT
Novartis (NOVN SW) Q3 2026 (USD): Net Sales 14.5bln (exp. 14.5bln), Adj. Operating Income 6.04bln (exp. 5.51bln), Core EPS 2.46 (exp. 2.28)
ORIGINAL · NewsquawkNovartis (NOVN SW) Q3 2026 (USD): Net Sales 14.5bln (exp. 14.5bln), Adj. Operating Income 6.04bln (exp. 5.51bln), Core EPS 2.46 (exp. 2.28)Read originalHide original
Entresto Sales 1.17bln Cosentyx Sales 1.86bln Guidance: Raises FY26 operating income to be in line to grow low single-digit (prev. guided decline low single-digit) Net sales to grow low single-digit.
StockNow breaking-news AI analysis
Novartis’s Q3 2026 breaking-news report showed net sales in line with estimates, adjusted operating income and core EPS above estimates, and raised FY26 operating-income guidance.
News detail
Entresto Sales 1.17bln Cosentyx Sales 1.86bln Guidance: Raises FY26 operating income to be in line to grow low single-digit (prev. guided decline low single-digit) Net sales to grow low single-digit.
Related stocks
1 stocks
What do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.